×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Syngene International Limited | 8951 | 1231 | 8771 | 3.06 | 28,731 | 60.2 |
| Narayana Hrudayalaya Limited | 8,736.95 | 792.23 | 8,650.43 | 3.90 | 28545 | 36.4 |
| Laurus Labs Limited | 14,244.70 | 929.40 | 14,150.50 | 1.71 | 28119 | 141.0 |
Syngene International Limited, with Security Code 539268, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 768.1 | 786.6 | 994.4 | 715.8 | 830.7 | 791.9 | 864.7 | 726.5 | 821.3 | 877.1 |
| Expenses | 552.4 | 556.2 | 678.0 | 552.4 | 614.1 | 592.4 | 565.4 | 578.3 | 612.7 | 626.3 |
| Operating Profit | 215.7 | 230.4 | 316.4 | 163.4 | 216.6 | 199.5 | 299.3 | 148.2 | 208.6 | 250.8 |
| OPM % | 28.08% | 29.29% | 31.82% | 22.83% | 26.07% | 25.19% | 34.61% | 20.4% | 25.4% | 28.59% |
| Other Income | 15.4 | 17.2 | 22.8 | 22.9 | 13.6 | 25.1 | 15.3 | 49.7 | 16.4 | 18.0 |
| Interest | 11.7 | 13.7 | 10.4 | 6.1 | 8.6 | 6.3 | 8.5 | 7.4 | 7.0 | 6.7 |
| Depreciation | 90.2 | 94.6 | 88.1 | 88.7 | 90.9 | 93.6 | 95.7 | 91.7 | 93.7 | 92.3 |
| Profit before tax | 129.2 | 139.3 | 240.7 | 91.5 | 138.1 | 128.4 | 210.4 | 66.8 | 124.3 | 169.8 |
| Tax % | 21.4% | 21.4% | 21.5% | 17.7% | 22.3% | 20% | 9.8% | 25.2% | 22.3% | 27.5% |
| Net Profit | 101.5 | 109.5 | 189.0 | 75.3 | 101.6 | 99.8 | 189.8 | 73.9 | 96.6 | 123.1 |
| EPS in Rs | 2.51 | 2.71 | 4.68 | 1.87 | 2.53 | 2.48 | 4.72 | 1.84 | 2.41 | 3.06 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 644.5 | 768.1 | 785.9 | 994.4 | 808.1 | 910.1 | 853.5 | 916.9 | 789.7 | 891.0 |
| Expenses | 471.7 | 551.6 | 554.9 | 680.3 | 596.2 | 656.0 | 622.0 | 600.0 | 619.9 | 646.2 |
| Operating Profit | 172.8 | 216.5 | 231.0 | 314.1 | 211.9 | 254.1 | 231.5 | 316.9 | 169.8 | 244.8 |
| OPM % | 26.8% | 28.2% | 29.4% | 31.6% | 26.2% | 27.9% | 27.1% | 34.6% | 21.5% | 27.5% |
| Other Income | 15.5 | 15.4 | 17.2 | 22.8 | 23.6 | 14.2 | 25.6 | 16.1 | 50.1 | 16.5 |
| Interest | 9.4 | 11.7 | 13.7 | 10.4 | 10.5 | 13.0 | 10.8 | 12.9 | 11.7 | 13.1 |
| Depreciation | 86.1 | 90.2 | 94.6 | 95.6 | 102.1 | 104.6 | 108.1 | 111.1 | 106.9 | 110.9 |
| Profit before tax | 92.8 | 130.0 | 139.9 | 230.9 | 122.9 | 158.1 | 141.9 | 209.0 | 69.3 | 137.3 |
| Tax % | 20.4% | 21.5% | 21.6% | 22.6% | 24% | 22.7% | 19.3% | 9.8% | 25.3% | 22.7% |
| Net Profit | 73.9 | 102.0 | 109.7 | 178.7 | 93.4 | 116.5 | 111.5 | 188.6 | 75.7 | 106.1 |
| EPS in Rs | 1 | 2 | 2 | 4 | 2 | 2 | 2 | 4 | 1 | 2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 7% |
| 3 Years: | 7% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 19% |
| 3 Years: | 9% |
| 1 Year: | -4% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 17% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 19% |
| 3 Years: | 9% |
| 1 Year: | -4% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|